UF Scientists Use AI Algorithm To Improve Strawberry Disease Detection
Won Suk “Daniel” Lee and Natalia Peres show how artificial intelligence (AI) can improve strawberry disease detection with a a system taking photos of a reference plate to water more directly than the current method.
How Our Brains Learn New Athletic Skills Fast
According to a study from the University of Florida biomechanical researchers, the quick, athletic learners among us are built differently – inside their brains.
Natural Ponds Remove Nitrogen More Effectively Than Stormwater Ponds, Researchers Find
Designed to control flooding, stormwater ponds are not as effective as natural ponds at removing nitrogen, a pollutant that can go downstream into lakes, rivers and other bodies of water, new University of Florida research shows.
What the Trained Eye Cannot See: Detecting Movement Defects in Early-Stage Parkinson’s Disease
A technique that uses videos and machine learning to quantify motor symptoms in early-stage Parkinson’s disease could help reveal signs of the disease and other movement disorders earlier, which could lead to better treatment outcomes.
Beer in Space: UF Researchers Study Microgravity’s Effect on Fermentation
A recently published study by University of Florida researchers provides insight into how beer yeast might behave when fermented in outer space.
Synthetic “Alien” DNA Provides Opportunities for Disease Diagnostics and Treatment
To help understand how DNA may have evolved on other planets, UF researcher Dr. Steven Benner and his partners synthesized DNA-like molecular systems with more than four nucleotides in the laboratory.
Atsena Therapeutics Receives Rare Pediatric Disease Designation From the U.S. FDA for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation (RPD) for ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Camera in Space to Capture the Impossible
Satlantis has been developing a camera to photograph the universe's dark matter -- which, by the way, is invisible.
First Type 1 Diabetes Patient Enrolled in Rise Therapeutics’ Latest Clinical Trial
Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, announced it has enrolled its first patient in its R-5280 placebo-controlled, blinded, Phase 1b type 1 diabetes clinical trial.
JPMorgan Upgrades Solid Biosciences Stock, Sees Growth Potential
JPMorgan upgraded Solid Biosciences stock, a biotechnology company that acquired UF startup AavantiBio, from Neutral to Overweight, and increased the price target to $15.00 from the previous $10.00. The firm's decision reflects a positive outlook on the company's prospects, particularly with upcoming developments expected in the fourth quarter.
